Scientist
Objective: Creation of highly precise genome editing agents for therapeutic genome editing and their preclinical applications in disease models. Systematic elucidation of nucleic acid interrogation properties of genome editing proteins for improving gene correction. Peptide based delivery of CRISPR components. Establish a disease-specific and gene corrected isogenic control iPSC repository for monogenic diseases that afflict Indian population. Identification of New CRISPR-Cas Components from Microbial Genomes and Metagenomes of Various Niches from India.